Martin J. Stoermer - Search Results

Year	Number of Results
2002	1
2003	1
2004	3
2005	2
2006	4
2007	2
2008	4
2009	2
2011	1
2012	2
2013	3
2014	2
2015	2
2016	1
2017	1
2024	0

1

Nielsen DS, Shepherd NE, Xu W, Lucke AJ, Stoermer MJ, Fairlie DP. Nielsen DS, et al. Among authors: stoermer mj. Chem Rev. 2017 Jun 28;117(12):8094-8128. doi: 10.1021/acs.chemrev.6b00838. Epub 2017 May 25. Chem Rev. 2017. PMID: 28541045 Review.

2

Potent heterocyclic ligands for human complement c3a receptor.

Reid RC, Yau MK, Singh R, Hamidon JK, Lim J, Stoermer MJ, Fairlie DP. Reid RC, et al. Among authors: stoermer mj. J Med Chem. 2014 Oct 23;57(20):8459-70. doi: 10.1021/jm500956p. Epub 2014 Oct 8. J Med Chem. 2014. PMID: 25259874

3

Structures of peptide agonists for human protease activated receptor 2.

Stoermer MJ, Flanagan B, Beyer RL, Madala PK, Fairlie DP. Stoermer MJ, et al. Bioorg Med Chem Lett. 2012 Jan 15;22(2):916-9. doi: 10.1016/j.bmcl.2011.12.029. Epub 2011 Dec 13. Bioorg Med Chem Lett. 2012. PMID: 22209488

4

Downsizing a human inflammatory protein to a small molecule with equal potency and functionality.

Reid RC, Yau MK, Singh R, Hamidon JK, Reed AN, Chu P, Suen JY, Stoermer MJ, Blakeney JS, Lim J, Faber JM, Fairlie DP. Reid RC, et al. Among authors: stoermer mj. Nat Commun. 2013;4:2802. doi: 10.1038/ncomms3802. Nat Commun. 2013. PMID: 24257095 Free article.

5

Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery.

Perry SR, Xu W, Wirija A, Lim J, Yau MK, Stoermer MJ, Lucke AJ, Fairlie DP. Perry SR, et al. Among authors: stoermer mj. J Chem Inf Model. 2015 Jun 22;55(6):1181-91. doi: 10.1021/acs.jcim.5b00087. Epub 2015 May 22. J Chem Inf Model. 2015. PMID: 26000704

6

Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Seow V, Lim J, Cotterell AJ, Yau MK, Xu W, Lohman RJ, Kok WM, Stoermer MJ, Sweet MJ, Reid RC, Suen JY, Fairlie DP. Seow V, et al. Among authors: stoermer mj. Sci Rep. 2016 Apr 20;6:24575. doi: 10.1038/srep24575. Sci Rep. 2016. PMID: 27094554 Free PMC article.

7

Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA.

Duprez W, Bachu P, Stoermer MJ, Tay S, McMahon RM, Fairlie DP, Martin JL. Duprez W, et al. Among authors: stoermer mj. PLoS One. 2015 Jul 30;10(7):e0133805. doi: 10.1371/journal.pone.0133805. eCollection 2015. PLoS One. 2015. PMID: 26225423 Free PMC article.

8

Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.

Moloney GP, Angus JA, Robertson AD, Stoermer MJ, Robinson M, Wright CE, McRae K, Christopoulos A. Moloney GP, et al. Among authors: stoermer mj. Eur J Med Chem. 2008 Mar;43(3):513-39. doi: 10.1016/j.ejmech.2007.04.007. Epub 2007 May 6. Eur J Med Chem. 2008. PMID: 17582659

9

Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds.

Ngoei KR, Ng DC, Gooley PR, Fairlie DP, Stoermer MJ, Bogoyevitch MA. Ngoei KR, et al. Among authors: stoermer mj. Biochim Biophys Acta. 2013 Jun;1834(6):1077-88. doi: 10.1016/j.bbapap.2013.02.001. Epub 2013 Feb 11. Biochim Biophys Acta. 2013. PMID: 23410953

10

Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity.

Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. Chappell KJ, et al. Among authors: stoermer mj. J Gen Virol. 2008 Apr;89(Pt 4):1010-1014. doi: 10.1099/vir.0.83447-0. J Gen Virol. 2008. PMID: 18343843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year